Correcting and replacing navidea biopharmaceuticals reports fourth quarter 2021 financial results

Dublin, ohio--(business wire)--this press release is being re-issued to revise the language in the selling, general and administrative bullet under financial results. that third bullet, third sentence should read: the net increase during the year to date was primarily due to separation expenses related to the resignation... (instead of the net increase during the year to date was primarily due to termination...) the updated release reads: navidea biopharmaceuticals reports fourth quarter 2021 f
NAVB Ratings Summary
NAVB Quant Ranking